Sylvain Lagneaux

Bioprofile SA develops, manufactures and markets orthopedic implants. The firm's main activities include developing, manufacturing and marketing of orthopedic implants intended to replace joints for patients suffering from arthritis. Bioprofile manufactures its orthopedic implants made of pyrolytic carbon or pyrocarbon. The company was founded by Cécile Réal in 1999 and is headquartered in Grenoble, France.

EndoControl SAS designs, develops and markets robotics solutions for laparoscopic surgeries. It markets a range of products including, ViKY EP, a laparoscopic motorized endoscope holder; ViKY UP, a motorized uterus positioner and; JAiMY, the first 5mm motorized articulated laparoscopic instrument with iD-Intelligent Dexterity. The company was founded by Clement Vidal and Patrick Henri in 2006 and is headquartered in Grenoble, France.

Patrick Choay SA operates as a holding company. The company is headquartered in Castelfranco Paris, France.

Remora Capital SA (Remora Capital) is a venture capital firm founded by Dr. Jean-Marc Le Doussal in 2009. The firm is headquartered in Switzerland.

KOELIS SAS provides engineering services. Its products include Trinity, 3D prostate suite, Mr-Draw and accessories. The company was founded by Antoine Leroy and Patrick Henry and is headquartered in Meylan, France.

Endodiag SAS develops diagnosis solutions which focused on patient screening and individual endometriosis characteristics. It offers early diagnosis, guiding decisions and new therapies. The company was founded by Jean Gogusev, Patric Henri, Cecile Marie Chloe Real and Jean Bouquet de la Joliniere in 2011 and is headquartered in Evry Cedex, France.

Abolis Biotechnologies SAS is a French industrial biotechnology company with a strong expertise in metabolic engineering for biosynthesis. The company is based in Evry, France and was founded in 2014 by Cyrille Pauthenier, Anthony Tschirhard, Jean-Loup Faulon, Cécile Marie Chloé Réal. The company has in-house know-how and unique tools to design and optimize metabolic pathways transforming sugars into molecules of interest. Abolis is developing bio-production processes for chemical molecules by fermentation of biomass.